Support from Bpifrance & Europe

Last updated : June 24, 2024

We are proud to announce that Kayentis has received support from Bpifrance & Europe for the development and industrialization of the Clin’form 3 clinical data management software platform.
This support allows us to accelerate the development of our new platform and to bring new functionalities to pharmaceutical companies and CROs.

Nous sommes fiers d’annoncer que Kayentis a reçu le soutien de Bpifrance et l’Europe pour le développement et l’industrialisation de la plateforme logicielle de gestion de données cliniques Clin’form 3.
Ce soutien nous permet ainsi d’accélérer le développement de notre nouvelle plateforme et d’apporter de nouvelles fonctionnalités au service des laboratoires pharmaceutiques et des CROs.

Subscribe to our newsletter

Turning experience into evidence: PROs in IBD clinical research

BYOD on the rise

Strategies to promote BYOD adoption by clinical study sites

How Kayentis reduces the CO2 emissions of your eCOA projects...

Empowering patients through data: a collaborative vision of clinical data...

If Patients Want A Better Quality Of Life, Why Isn’t...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

5th Annual Clinical Trial Innovation Summit

JUNE 26, 2025 • Basel, CH

Clinical Trial Innovation Summit 2025 | June 26, 2025

The reckless value of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET

In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....